Migrastat

product on market Tablet or Pill Headache Free Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 67% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Magnesium, willow, and ginger are used to address headache symptoms, with research suggesting moderate evidence for their efficacy in reducing pain and inflammation. These ingredients target vascular tension and nausea associated with migraines. The overall evidence coverage for this specific profile remains limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Migrastat
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
24
Servings
Botanical with Nutrients
Product Type
67%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

50 mg (12.5% DV)
Within RDA (0.1× RDA) 316 studies (A:8, B:159)
Willow
60 mg
250 mg
Market median: 250.0mg (337 products) 127 studies (A:1, B:41)

Other Ingredients

Sorbitol Stearic Acid Croscarmellose Sodium Silicon Dioxide Magnesium Stearate Shellac Talc Carnauba Wax
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Warnings & Precautions

Warning: People with an aspirin allergy or sensitivity should not take Willow Bark.

Taking Willow Bark along with aspirin might increase the effects and side effects of aspirin. Willow Bark might slow blood clotting.

Taking Willow Bark along with medications that also slow clotting might increase the chances of bruising and bleeding. Medications that slow blood clotting (Anticoagulant/Antiplatelet drugs) interacts with Willow Bark.

Formulation Notes

This product contains no known allergens: Starch, Gluten, Soy, Dairy, Animal By-Products, Sugar, Artificial Flavoring, or Digestible Plastics.

Physician-formulated with Willow Bark, Magnesium, and Ginger Root to quickly and naturally stop headache.

~ No starch, gluten, or soy ~ No dairy or animal by-products ~ No salt, sugar, or artificial flavoring/coloring ~ No digestible plastic

We are proud to present Migrastat(R), a combination of Willow Bark, a natural anti-inflammatory; Ginger root, a natural anti-emetic; and magnesium which may be deficient in headache sufferers and has been shown to be effective in the treatment of headache, especially when given intravenously.

~ Contains no known allergens

Additional Information

Together, these three natural substances can relieve both headache and associated nausea. {signature} Gary A. L'Europa, MD, FAHS U.S. Board-certified in Neurology and Headache Management Natural Acute Headache Relief

Immediate Headache Relief

Migrastat uses all natural sources, Willow Bark, Ginger, and Magnesium, to combat headaches when they start. Migrastat is best used in conjunction with HeadacheFree, a natural preventative for headache.

Migrastat is made using a blend of both food-based and natural ingredients, for maximum and immediate absorption.

Distributed by Headache Free, LLC headquartered in Warwick, RI 02886

Since the development of HeadacheFree we have been frequently asked about an all natural as-needed formulation for the acute treatment of headache.

~ Fast Acting ~ 100% Natural ~ Less side effects

~ Developed by a board certified neurologist

Metadata

Product Details

DSLD Entry Date2014-06-25
Product TypeBotanical with Nutrients
FormTablet or Pill
DSLD ID34180
Data Updated2026-04-11
Research

Research Evidence

849
Research Sources
56
Avg Quality
450
Meta Analysis
152
Rct
137
Systematic Review
73
Clinical Trial
11
Regulatory Source
7
Other
7
Guideline
3
Openfda Safety
2
Cochrane Review
2
Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019 PubMed DOI
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Electrolytes →
Compare

Similar Products

View all Electrolytes products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.